Strategy for Mitigating DKA Risk in Patients with Type 1 Diabetes on Adjunctive Treatment with SGLT Inhibitors: A STICH Protocol

被引：83
|
作者：
Garg, Satish K. [1 ,2 ]
Peters, Anne L. [3 ]
Buse, John B. [4 ]
Danne, Thomas [5 ]
机构：
[1] Univ Colorado Denver, Sch Med, Dept Med & Pediat, Aurora, CO USA
[2] Barbara Davis Ctr Diabet, Aurora, CO USA
[3] Univ Southern Calif, Keck Sch Med, Los Angeles, CA USA
[4] Univ N Carolina, Sch Med, Chapel Hill, NC 27515 USA
[5] Hannover Med Sch, Childrens & Youth Hosp Bult, Hannover, Germany
来源：
DIABETES TECHNOLOGY & THERAPEUTICS | 2018年 / 20卷 / 09期
关键词：
INSULIN; KETOACIDOSIS; DAPAGLIFLOZIN; CHILDREN; STATE;
D O I：
10.1089/dia.2018.0246
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：571 / 575
页数：5
相关论文
共 50 条
  • [21] The Potential Role of SGLT2 Inhibitors in the Treatment of Type 1 Diabetes Mellitus
    Fattah, Hadi
    Vallon, Volker
    DRUGS, 2018, 78 (07) : 717 - 726
  • [22] The Potential Role of SGLT2 Inhibitors in the Treatment of Type 1 Diabetes Mellitus
    Hadi Fattah
    Volker Vallon
    Drugs, 2018, 78 : 717 - 726
  • [23] Metformin as an adjunctive treatment for type 1 diabetes
    不详
    DIABETES OBESITY & METABOLISM, 2003, 5 (03): : 208 - 208
  • [24] SGLT inhibition in patients with type 1 diabetes
    Dehn, Clayton A.
    LANCET DIABETES & ENDOCRINOLOGY, 2014, 2 (07): : 539 - 539
  • [25] SGLT2 inhibitors in Type 1 diabetes: is this the future?
    Herring, R.
    Russell-Jones, D. L.
    DIABETIC MEDICINE, 2018, 35 (12) : 1642 - 1643
  • [26] SGLT Inhibitors for Type 1 Diabetes: Proceed With Extreme Caution
    Wolfsdorf, Joseph I.
    Ratner, Robert E.
    DIABETES CARE, 2019, 42 (06) : 991 - 993
  • [27] SGLT2 Inhibitors: The Star in the Treatment of Type 2 Diabetes?
    Saisho, Yoshifumi
    DISEASES, 2020, 8 (02)
  • [28] Patients with type 1 diabetes: Perceptions associated with pramlintide as an adjunctive treatment to insulin
    Marrero, D
    Kruger, D
    Burrell, T
    Gloster, M
    Crean, J
    Herrmann, K
    Kolterman, O
    DIABETES, 2004, 53 : A137 - A138
  • [29] Glucagon in type 1 diabetes patients receiving SGLT2 inhibitors: A Friend or Foe?
    Fukui, Tomoyasu
    Ohara, Makoto
    Yamagishi, Sho-ichi
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2021, 37 (05)
  • [30] Dapagliflozin: an effective adjunctive treatment in type 1 diabetes
    Yadegarfar, Ghasem
    Livingston, Mark
    Cortes, Gabriela
    Alshames, Ramadan
    Leivesley, Kate
    Metters, Ann
    Horne, Linda
    Steele, Tom
    Heald, Adrian H.
    CARDIOVASCULAR ENDOCRINOLOGY & METABOLISM, 2021, 10 (02): : 132 - 136
12345